Showing items 1 - 2 of 2

Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial

- Siva, Shankar, Bressel, Mathias, Lin, Charles, Raman, Avi, Hardcastle, Nicholas, Hofman, Michael S., De Abreu Lourenco, Richard, Shaw, Mark, Mancuso, Pascal, Moon, Daniel, Wong, Lih-Ming, Lawrentschuk, Nathan, Sidhom, Mark, Wood, S, Brook, NR, Kron, T, Martin, Jarad, Pryor, D, FASTRACK II Investigator Group,, Sridharan, Swetha, Vanneste, Ben G. L., Davey, Ryan, Montgomery, Rebecca, Ruben, Jeremy, Foroudi, Farshad, Higgs, Braden

Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men with Nonmetastatic Prostate Cancer in Australia and New Zealand

- Pryor, David I., Martin, Jarad M., Syed, Farhan, Hayden, Amy J., Turner, Sandra L., Papa, Nathan, Millar, Jeremy L., Day, Heather, Ong, Wee Loon, Skala, Marketa, Fitzgerald, Liesel M., Hindson, Benjamin, Higgs, Braden, O'Callaghan, Michael E.

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit